The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2018

Filed:

Dec. 30, 2016
Applicant:

California Institute of Technology, Pasadena, CA (US);

Inventors:

Carlos Lois-Caballe, Cambridge, MA (US);

David Baltimore, Pasadena, CA (US);

Xiao-Feng Qin, Sugarland, TX (US);

Irvin S. Y. Chen, Palos Verdes Estates, CA (US);

Dong Sung An, Los Angeles, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 15/867 (2006.01); A61K 48/00 (2006.01); A61P 31/18 (2006.01); C12N 15/86 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1132 (2013.01); C12N 15/111 (2013.01); C12N 15/1138 (2013.01); C12N 15/86 (2013.01); A61K 48/00 (2013.01); C12N 2310/111 (2013.01); C12N 2310/14 (2013.01); C12N 2740/16043 (2013.01); C12N 2740/16045 (2013.01); C12N 2799/027 (2013.01); C12N 2810/609 (2013.01); C12N 2830/003 (2013.01); C12N 2830/008 (2013.01); C12N 2840/203 (2013.01);
Abstract

In one aspect, the invention provides methods and compositions for the expression of small RNA molecules within a cell using a retroviral vector (FIG.A). Small interfering RNA (siRNA) can be expressed using the methods of the invention within a cell. In a further aspect, the invention provides methods for producing siRNA encoding lentivirus where the siRNA activity may interfere with the lentiviral life cycle. In yet a further aspect, the invention provides methods for expression of a small RNA molecule within a cell, such as an siRNA capable of downregulating CCR5, wherein expression of the small RNA molecule is relatively non-cytotoxic to the cell. The invention also includes small RNA molecules, such as an siRNA capable of downregulating CCR5, that are relatively non-cytotoxic to cells.


Find Patent Forward Citations

Loading…